Thus, to achieve a better understanding on the methylome changes in CLL patients and how they might be connected to mutations in SF3B1, we compared genome-wide methylation profiles of CLL patients with (SF3B1mut) and without (SF3B1WT) SF3B1 mutations. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.